Recurrent clostridium difficile infection in a patient with selective IgG1 deficiency treated with intravenous immune globulin and saccharomyces boulardii

Clinical Infectious Diseases

Volumn 20, Issue , 1995, Pages S266-S268

  Hassett, Joseph ^a,b,c,d   Meyers, Samuel ^a,b,c,d   McFarland, Lynne ^a,b,c,d   Mulligan, Maury Ellis ^a,b,c,d  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

ADULT; ANTIBODY BLOOD LEVEL; CASE REPORT; CLOSTRIDIUM DIFFICILE; CONFERENCE PAPER; FEMALE; HUMAN; IMMUNOGLOBULIN DEFICIENCY; INFECTION RISK; PRIORITY JOURNAL; RECURRENT INFECTION; SACCHAROMYCES BOULARDII;

ANTIBODIES, BACTERIAL; BACTERIAL TOXINS; CASE REPORT; CLOSTRIDIUM DIFFICILE; DIARRHEA; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HUMAN; IGG DEFICIENCY; IMMUNOGLOBULIN G; IMMUNOGLOBULINS, INTRAVENOUS; MIDDLE AGE; RECURRENCE; SACCHAROMYCES;

EID: 0028997769     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/clinids/20.Supplement_2.S266     Document Type: Article

References (9)

1. Warny M, Vaerman JP, Avesani V, Delmee M. Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection. Infect Immun 1994;62:384-9.
2. Mulligan ME, Miller SD. McFarland LV, Fung HC, Kwok RY. Elevated levels of serum immunoglobulins in asymptomatic carriers of Clostridium difficile. Clin Infect Dis 1993; 16(suppl 4):S239-44.
3. Gryboski JD, Pellerano R, Young N, Edberg S. Positive role of Clostridium difficile infection in diarrhea in infants and children. Am J Gastroenterol 1991;86:685-9.
4. Perlmutter DH, Leichtner AM, Goldman H, Winter HS. Chronic diarrhea associated with hypogammaglobulinemia and enteropathy in infants and children. Dig Dis Sei 1985;30:1149-55.
5. McFarland LV, Surawicz CM, Greenberg RN, et al. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA 1994; 271:1913-8.
6. McFarland LV, Bernasconi P. Saccharomyces boulardii: a review of an innovative biotherapeutic agent. Microbial Ecology in Health and Disease 1993;6:157-71.
7. Pothoulakis C, Kelly CP, Joshi MA, et al. Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum. Gastroenterology 1993;104:1108-15.
8. Chang TM, Lauermann M, Bartlett JG. Cytotoxicity assay in antibiotic- associated colitis. J Infect Dis 1979;5:765-70.
9. Leung DY, Kelly CP, Boguniewicz M, Pothoulakis C, LaMont JT, Flores A. Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium Difficile toxin. J Pediatr 1991; 118:633-7.